Carine GIOVANNANGELI
Directrice de Recherche
Entité de rattachement
Équipe GE2R
Contact
Courriel
carine.giovannangeli [at] mnhn.fr
Téléphone
01 40 79 37 11
Adresse(s)
CNRS UMR 7196 / INSERM U1154
43, rue Cuvier - Case Postale 26
75231 Paris Cedex 05, France
Responsabilités dans l'unité
Chef d’équipe GE2R
Publications
2024
- , janvier 2024 — Comparative transcriptomics reveal a novel tardigrade specific DNA binding protein induced in response to ionizing radiation. eLife , ,
2022
- , décembre 2022 — De novo generation of the NPM-ALK fusion recapitulates the pleiotropic phenotypes of ALK+ ALCL pathogenesis and reveals the ROR2 receptor as target for tumor cells. Molecular Cancer vol. 21, n° 1, dir. {BioMed Central} p. 65
- , novembre 2022 — Base-editing-mediated dissection of a γ-globin cis-regulatory element for the therapeutic reactivation of fetal hemoglobin expression. Nature Communications vol. 13, n° 1, p. 6618
- , juin 2022 — Disease modeling by efficient genome editing using a near PAM-less base editor in vivo. Nature Communications vol. 13, n° 1, dir. {Nature Publishing Group} p. 3435
2021
- , octobre 2021 — Recent Progress in Genome Editing for Gene Therapy Applications: The French Perspective. Human Gene Therapy vol. 32, 19-20, dir. {Mary Ann Liebert} p. 1059-1075
- , octobre 2021 — Unraveling Ewing Sarcoma Tumorigenesis Originating from Patient-Derived Mesenchymal Stem Cells. Cancer Research vol. 81, n° 19, dir. {American Association for Cancer Research} p. 4994-5006
2020
- , février 2020 — Editing a \gamma-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype. Science Advances vol. 6, n° 7, dir. {American Association for the Advancement of Science (AAAS)} eaay9392
2019
- , 2019 — Differential Requirements for the RAD51 Paralogs in Genome Repair and Maintenance in Human Cells. PLoS Genetics vol. 15, n° 10, dir. {Public Library of Science} e1008355
2018
- , décembre 2018 — High doses of CRISPR/Cas9 ribonucleoprotein efficiently induce gene knockout with low mosaicism in the hydrozoan Clytia hemisphaerica through microhomology-mediated deletion. Scientific Reports vol. 8, n° 1, dir. {Nature Publishing Group}
- , juillet 2018 — The Xenopus tadpole: an in vivo model to screen drugs favoring remyelination. Multiple Sclerosis Journal vol. 24, n° 11, dir. {SAGE Publications} p. 1421-1432